Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein

Hypertension

Volumn 61, Issue 1, 2013, Pages 253-258

  Herrera, Marcela ^a   Sparks, Matthew A ^a   Alfonso Pecchio, Adolfo R ^b   Harrison Bernard, Lisa M ^c   Coffman, Thomas M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin II type 1 receptor; AT1A; AT1B; cross reactivity; Western blot

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTIBODY; MESSENGER RNA; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY HOMOGENATE; KIDNEY PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; VASOCONSTRICTION; WESTERN BLOTTING;

ANIMALS; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; IMMUNOHISTOCHEMISTRY; KIDNEY; MICE; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 84871606715     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.203679     Document Type: Article

References (29)

1. Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA, Allen AM, Haase VH, Snouwaert JN, Le TH, McDonough AA, Koller BH, Coffman TM. AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab. 2011;13:469-475.
2. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA. 2006;103:17985-17990. (Pubitemid 44852272)
3. 1 receptor-mediated salt retention in angiotensin II-dependent hypertension. Am J Physiol Renal Physiol. 2011;301:F1124-F1130.
4. Lai EY, Solis G, Luo Z, Carlstrom M, Sandberg K, Holland S, Wellstein A, Welch WJ, Wilcox CS. p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice. Hypertension. 2012;59:415-420.
5. Masuda T, Muto S, Fujisawa G, Iwazu Y, Kimura M, Kobayashi T, Nonaka-Sarukawa M, Sasaki N, Watanabe Y, Shinohara M, Murakami T, Shimada K, Kobayashi E, Kusano E. Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2012;302:H1871-H1883.
6. Polichnowski AJ, Lu L, Cowley AW Jr. Renal injury in angiotensin II+L-NAME-induced hypertensive rats is independent of elevated blood pressure. Am J Physiol Renal Physiol. 2011;300:F1008-F1016.
7. Varagic J, Frohlich ED, Susic D, Ahn J, Matavelli L, López B, Díez J. AT 1 receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressure. Am J Physiol Heart Circ Physiol. 2008;294:H853-H858. (Pubitemid 351253296)
8. Rateri DL, Moorleghen JJ, Balakrishnan A, Owens AP 3rd, Howatt DA, Subramanian V, Poduri A, Charnigo R, Cassis LA, Daugherty A. Endothelial cell-specifc defciency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/-mice. Circ Res. 2011;108:574-581.
9. Iwai N, Yamano Y, Chaki S, Konishi F, Bardhan S, Tibbetts C, Sasaki K, Hasegawa M, Matsuda Y, Inagami T. Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression. Biochem Biophys Res Commun. 1991;177:299-304.
10. Kakar SS, Sellers JC, Devor DC, Musgrove LC, Neill JD. Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation. Biochem Biophys Res Commun. 1992;183:1090-1096.
11. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-236. (Pubitemid 21896571)
12. Deslauriers B, Ponce C, Lombard C, Larguier R, Bonnafous JC, Marie J. N-glycosylation requirements for the AT1a angiotensin II receptor delivery to the plasma membrane. Biochem J. 1999;339 (pt 2):397-405. (Pubitemid 29209971)
13. Benicky J, Hafko R, Sanchez-Lemus E, Aguilera G, Saavedra JM. Six Commercially Available Angiotensin II AT(1) Receptor Antibodies are Non-specifc. Cell Mol Neurobiol. July 28, 2012. DOI: 10.1007/s10571-012-9862-y.http://www. springerlink.com/content/c124121217554717/. Accessed November 2, 2012.
14. Park S, Bivona BJ, Harrison-Bernard LM. Compromised renal micro-vascular reactivity of angiotensin type 1 double null mice. Am J Physiol Renal Physiol. 2007;293:F60-F67. (Pubitemid 47345004)
15. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA. 1995;92:3521-3525.
16. Oliverio MI, Kim HS, Ito M, Le T, Audoly L, Best CF, Hiller S, Kluckman K, Maeda N, Smithies O, Coffman TM. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci USA. 1998;95:15496-15501. (Pubitemid 29018727)
17. Harrison-Bernard LM, Imig JD, Carmines PK. Renal AT1 receptor protein expression during the early stage of diabetes mellitus. Int J Exp Diabetes Res. 2002;3:97-108. (Pubitemid 34477464)
18. Hoffmann A, Cool DR. Characterization of two polyclonal peptide antibodies that recognize the carboxy terminus of angiotensin II AT1A and AT1B receptors. Clin Exp Pharmacol Physiol. 2005;32:936-943. (Pubitemid 43906832)
19. Harrison-Bernard LM, Navar LG, Ho MM, Vinson GP, el-Dahr SS. Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol. 1997;273(1 pt 2):F170-F177.
20. Barker S, Marchant W, Ho MM, Puddefoot JR, Hinson JP, Clark AJ, Vinson GP. A monoclonal antibody to a conserved sequence in the extracellular domain recognizes the angiotensin II AT1 receptor in mammalian target tissues. J Mol Endocrinol. 1993;11:241-245.
21. Paxton WG, Runge M, Horaist C, Cohen C, Alexander RW, Bernstein KE. Immunohistochemical localization of rat angiotensin II AT1 receptor. Am J Physiol. 1993;264(6 pt 2):F989-F995. (Pubitemid 23198545)
22. Pradidarcheep W, Labruyère WT, Dabhoiwala NF, Lamers WH. Lack of specifcity of commercially available antisera: better specifcations needed. J Histochem Cytochem. 2008;56:1099-1111.
23. Rhodes KJ, Trimmer JS. Antibodies as valuable neuroscience research tools versus reagents of mass distraction. J Neurosci. 2006;26:8017-8020. (Pubitemid 44315124)
24. Lu X, Bartfai T. Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice. Naunyn Schmiedebergs Arch Pharmacol. 2009;379:417-420.
25. Jensen BC, Swigart PM, Simpson PC. Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecifc. Naunyn Schmiedebergs Arch Pharmacol. 2009;379:409-412.
26. Hamdani N, van der Velden J. Lack of specifcity of antibodies directed against human beta-adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol. 2009;379:403-407.
27. Pradidarcheep W, Stallen J, Labruyère WT, Dabhoiwala NF, Michel MC, Lamers WH. Lack of specifcity of commercially available antisera against muscarinergic and adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol. 2009;379:397-402.
28. Roy SF, Laporte SA, Escher E, Leduc R, Guillemette G. Epitope tagging and immunoreactivity of the human angiotensin II type 1 receptor. Can J Physiol Pharmacol. 1997;75:690-695. (Pubitemid 27458658)
29. Burson JM, Aguilera G, Gross KW, Sigmund CD. Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol. 1994;267(2 pt 1):E260-E267.